Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Q4 2024 Earnings Call Transcript February 19, 2025 Outset Medical, Inc. beats earnings expectations. Reported EPS is $-0.37, ...

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Outset Medical (OM – Research Report), with a price ...

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Outset Medical (OM – Research Report) yesterday and set a price target of ...

Outset Medical (OM) reports Q4 2024 revenue growth, improved margins, & reduced expenses. Learn about 2025 growth plans & profitability focus.

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.59 per share a year ago. These figures ...

During the fourth quarter, Outset Medical made significant progress. Gross margin, essential for profitability, improved dramatically. It reached 37.7%, reflecting operational efficiencies compared to ...

Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.